Skip to main content
. Author manuscript; available in PMC: 2024 Nov 1.
Published in final edited form as: Bone Marrow Transplant. 2024 Feb 20;59(5):653–659. doi: 10.1038/s41409-024-02239-w

Table 1:

Return to school SOPs provided by HCT center directors

Centers Description
1 Allogeneic: At least 9 months before returning to school
2 Both Allogeneic and Autologous: At least 6–12 months before returning to school
Allogeneic: Ok to go back to school after 1 year even on IST
3 Autologous: Minimum 3 months
Allogeneic related donor: Minimum 6 months
Allogeneic unrelated donor: Minimum 12 months
Allogeneic: Check lymphocyte subsets in to verify adequate immunologic function to return
4 Autologous: At least 3 months
Allogeneic: At least 6 months and receiving vaccines
5 Both Allogeneic and Autologous: At 1-year post-BMT
6 Allogeneic: off or tapering GVHD meds, CD4+ >200/uL, and receiving vaccines
7 Autologous: ALC >1000/uL, CD4 =200/uL
Allogeneic: no GVHD ≥Grade II, ALC >1000/uL, CD4 >400/uL, weaning immunosuppression
8 Allogeneic and Autologous: Response to mitogen & antigen-stimulated lymphocyte proliferation & ready to receive vaccines
Allogeneic: No active, uncontrolled GVHD
9 Multiple factors are considered; psychosocial readiness, fatigue, immune suppression, etc.
10 Allogeneic: At least 6 months, receiving vaccines, central catheter removed, and no active GVHD requiring >0.5 mg/kg/day prednisone or ≥2 lines of immunosuppressive therapy
11 Allogeneic: off immune suppression, without active GVHD; with normal ANC and lymphocyte counts; CD4 >400/uL and immunoglobulin levels within normal range for age; receiving vaccines
12 Autologous: after day 50 or at the discretion of primary oncologist and ANC >2000/uL
Allogeneic: at least 6–12 months and off systemic immunosuppression

IST= immune suppressive therapy; BMT= bone marrow transplant; GVHD= graft vs. host disease; ALC=absolute lymphocyte count; ANC=absolute neutrophil count